SEC Filing Summary: Ra Medical Systems, Inc. (RMED)
Business Context and Reporting Period
This Form 8-K was filed on May 11, 2021, by Ra Medical Systems, Inc. (not Catheter Precision, Inc., as noted in the request metadata). The filing serves to announce the Company's financial results for the three months ended March 31, 2021. The Company is incorporated in Delaware and trades on the NYSE American under the symbol RMED.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release attached as Exhibit 99.1, which is incorporated by reference but not reproduced in the provided text.
Material Changes
The filing does not explicitly detail material changes versus the prior comparable period within the main body text. Investors must refer to the attached press release (Exhibit 99.1) for comparative financial analysis.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information furnished in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into any registration statement unless expressly stated. No specific guidance, outlook, or risk factors are detailed in the provided text.
Investor Verification Checklist
- Verify the specific revenue and net loss figures for the quarter ended March 31, 2021, in the attached press release (Exhibit 99.1).
- Confirm the Company's cash position and liquidity runway as detailed in the full financial results.
- Review the press release for any updates on product development, regulatory approvals, or strategic partnerships.
- Note that the filing explicitly excludes the financial data from being "filed" under Section 18 liability standards.